Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      ArisGlobal lanza NavaX Translation para eliminar la traducción manual en la farmacovigilancia global

      ArisGlobal Logo

      News provided by

      ArisGlobal

      Feb 26, 2026, 10:12 ET

      Share this article

      Share this article


      La alianza estratégica con TransPerfect Life Sciences integra la traducción certificada de grado farmacéutico directamente en los flujos de trabajo de LifeSphere Safety.

      BOSTON, 26 de febrero de 2026 /PRNewswire/ -- ArisGlobal, una empresa tecnológica líder en IA en el sector de las ciencias de la vida y creadora de LifeSphere®, anunció recientemente el lanzamiento de NavaX Translation, una nueva solución desarrollada a través de una alianza estratégica con TransPerfect Life Sciences. NavaX Translation integra traducción certificada de calidad farmacéutica y contenido multilingüe directamente en los flujos de trabajo de LifeSphere Safety, lo que permite un procesamiento de casos multilingüe más rápido, preciso y totalmente compatible a escala global.

      Los equipos globales de farmacovigilancia se enfrentan a un volumen cada vez mayor de informes de seguridad presentados en varios idiomas, lo que a menudo requiere exportación manual, coordinación con proveedores externos, revisión local y reimportación a los sistemas de seguridad. NavaX Translation elimina esta fricción por completo.

      Mediante la detección inteligente de idiomas, los formularios de seguridad que no están en inglés se identifican automáticamente y se envían para su traducción certificada mediante modelos de IA específicos para la industria farmacéutica y lingüistas humanos expertos de TransPerfect. Los formularios y datos traducidos se devuelven sin problemas a LifeSphere Safety a través de la API, lo que reduce la gestión de la traducción de horas de trabajo manual por caso a minutos.

      NavaX Translation está diseñado específicamente para entornos regulados de ciencias de la vida, combinando la eficiencia de la IA con la experiencia lingüística humana:

      • Admisión multilingüe automatizada con detección instantánea de idioma
      • Traducciones certificadas de calidad farmacéutica mediante modelos específicos para ciencias de la vida y lingüistas expertos
      • Integración fluida de API con LifeSphere Safety: sin exportación ni reimportación manual
      • Resultados listos para el cumplimiento normativo que cumplen con los requisitos regulatorios globales
      • Operaciones escalables para la admisión de casos de gran volumen en múltiples mercados

      "NavaX Translation refleja nuestro compromiso de integrar la automatización inteligente directamente en los flujos de trabajo principales", afirmó Jason Bryant, vicepresidente sénior de IA y Gestión de Productos de Datos. "Al asociarnos con TransPerfect, ofrecemos una traducción que cumple con los requisitos de calidad, cumplimiento normativo y escalabilidad de la farmacovigilancia global, sin añadir complejidad operativa".

      Este lanzamiento se basa en el continuo impulso de la plataforma NavaX, que actualmente procesa más de un millón de casos de seguridad, con un volumen proyectado que alcanzará los 2,5 millones de casos para mediados de 2026. Las métricas de rendimiento de NavaX siguen demostrando una precisión de datos superior al 95 %, mejoras de eficiencia superiores al 30 % y un retorno de la inversión (ROI) líder en el sector.

      "Al asociarnos con ArisGlobal, integramos la traducción validada en una plataforma de seguridad verdaderamente inteligente, lo que permite a las organizaciones de ciencias de la vida expandirse globalmente con confianza, rapidez y garantía regulatoria", afirmó Kevin Obarski, director de Crecimiento de TransPerfect.

      NavaX Translation está disponible para los clientes de LifeSphere Safety a partir de julio de 2026.

      Para obtener más información sobre NavaX Translation, visite: NavaX Translation | ArisGlobal

      Acerca de ArisGlobal
      ArisGlobal, una innovadora empresa de tecnología de ciencias de la vida y creadora de LifeSphere®, está transformando la forma en que las empresas de ciencias de la vida más exitosas de la actualidad desarrollan innovaciones y comercializan nuevos productos. Con sede en Estados Unidos, ArisGlobal cuenta con oficinas regionales en Europa, India, Japón y China. Para más información, siga a ArisGlobal en LinkedIn. www.arisglobal.com. 

      Acerca de TransPerfect Life Sciences
      TransPerfect Life Sciences se especializa en apoyar el desarrollo y la comercialización global de medicamentos, tratamientos y dispositivos diseñados para mejorar y salvar vidas. Nuestras soluciones integrales incluyen tecnologías eTMF y eClinical, migración de TMF en papel, soluciones de farmacovigilancia y seguridad, servicios de traducción e idiomas, y soporte de centro de llamadas. Con oficinas en más de 100 ciudades de todo el mundo, TransPerfect es el socio ideal para garantizar que su lanzamiento global tenga un impacto global. Para más información, visite nuestro sitio web en https://lifesciences.transperfect.com/.

      Logo - https://mma.prnewswire.com/media/1510670/ArisGlobal_Logo.jpg 

      Modal title

      Also from this source

      ArisGlobal lance NavaX Translation pour éliminer la traduction manuelle dans la pharmacovigilance mondiale

      ArisGlobal lance NavaX Translation pour éliminer la traduction manuelle dans la pharmacovigilance mondiale

      ArisGlobal, société de technologie axée sur l'IA à l'avant-garde des sciences de la vie et créateur de LifeSphere®, a récemment annoncé le lancement...

      ArisGlobal bringt NavaX Translation auf den Markt, um manuelle Übersetzungen in der globalen Pharmakovigilanz zu eliminieren

      ArisGlobal bringt NavaX Translation auf den Markt, um manuelle Übersetzungen in der globalen Pharmakovigilanz zu eliminieren

      ArisGlobal, ein führendes KI-Technologieunternehmen im Bereich Life Sciences und Entwickler von LifeSphere®, hat kürzlich die Einführung von NavaX...

      More Releases From This Source

      Explore

      Computer & Electronics

      Computer & Electronics

      Medical Pharmaceuticals

      Medical Pharmaceuticals

      Artificial Intelligence

      Artificial Intelligence

      Computer Software

      Computer Software

      News Releases in Similar Topics

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.